Get the Stockscreener App
1.18
0.85%
0.01
After Hours:
1.19
0.01
+0.85%
Sellas Life Sciences Group Inc Stock (SLS) Forecast
The Sellas Life Sciences Group Inc (SLS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.6303, representing a +377.14% increase from the current price of $1.18. The highest analyst price target is $7.2342, and the lowest is $4.0263.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SLS Price Target
Average 4.5255
(+283.52% Upside)
Is Sellas Life Sciences Group Inc (SLS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.25 | Neutral |
| STOCH(9,6) | 62.30 | Neutral |
| STOCHRSI(14) | 64.42 | Neutral |
| MACD(12,26) | -0.0146 | Sell |
| ADX(14) | 24.30 | Neutral |
| William %R | -52.17 | Neutral |
| CCI(14) | -32.98 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.181
Sell
|
1.1886
Sell
|
| MA20 |
1.20
Sell
|
1.1997
Sell
|
| MA50 |
1.2332
Sell
|
1.2195
Sell
|
| MA100 |
1.2166
Sell
|
1.2268
Sell
|
| MA200 |
1.1913
Sell
|
1.2367
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SLS could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on SLS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.25 indicates that SLS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 62.3 indicates that SLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.42 indicates that SLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.3 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -32.98 indicates that SLS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term SLS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sellas Life Sciences Group Inc financial reports and earnings history, Sellas Life Sciences Group Inc (SLS) stock could reach $1.6208 by 2030, $3.0499 by 2040 and $9.3022 by 2050. See the projected annual prices until 2050 of the Sellas Life Sciences Group Inc stock below:
- Sellas Life Sciences Group Inc (SLS) is expected to reach an average price of $1.9525 in 2035, with a high prediction of $2.0892 and a low estimate of $1.7098. This indicates an $65.47% rise from the last recorded price of $1.18.
- Sellas Life Sciences Group Inc (SLS) stock is projected to chart a bullish course in 2040, with an average price target of $2.7161, representing an $130.18% surge from its current level. The forecast ranges from a conservative $2.6311 to a sky-high $3.0499.
- Our analysts predict Sellas Life Sciences Group Inc (SLS) to jump 212.96% by 2045, soaring from $3.613 to an average price of $3.693, potentially reaching $4.8579. While $3.613 is the low estimate, the potential upside is significant.
- Sellas Life Sciences Group Inc (SLS) stock is expected to climb by 2050, reaching an average of $9.0972, a $670.95% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.3022 and $6.7451, respectively, highlighting the market's uncertainty.
Sellas Life Sciences Group Inc Stock (SLS) Year by Year Forecast
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2024
Our forecast for SLS stock price in 2024 now indicates an average price target of $3.8411 with a high forecast of $7.2342 and a low forecast of $0.4479. The average prediction reflects an increase of +225.52% from the last recorded price of $1.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $4.4238 | $4.0263 | $7.2342 | +274.90% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2025
Sellas Life Sciences Group Inc Stock (SLS) is expected to reach an average price of $3.4559 in 2025, with a high prediction of $5.0951 and a low estimate of $1.8168. This indicates an +192.87% rise from the last recorded price of $1.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.2659 | $3.8951 | $5.0951 | +261.52% |
| February, 2025 | $3.1676 | $3.0576 | $4.6563 | +168.44% |
| March, 2025 | $2.3882 | $2.3692 | $4.065 | +102.39% |
| April, 2025 | $2.0963 | $1.9786 | $2.7697 | +77.66% |
| May, 2025 | $2.203 | $1.8168 | $2.4327 | +86.70% |
| June, 2025 | $3.2247 | $2.2327 | $3.4847 | +173.28% |
| July, 2025 | $3.4468 | $3.2464 | $4.3355 | +192.10% |
| August, 2025 | $3.3384 | $3.0784 | $3.9722 | +182.92% |
| September, 2025 | $3.8201 | $3.1189 | $4.7997 | +223.74% |
| October, 2025 | $2.2522 | $2.1322 | $3.9005 | +90.87% |
| November, 2025 | $3.0239 | $2.1426 | $3.283 | +156.26% |
| December, 2025 | $2.936 | $2.8343 | $3.2056 | +148.81% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2026
The predicted value for Sellas Life Sciences Group Inc (SLS) in 2026 is set at an average of $11.23. Estimates vary from a peak of $19.76 to a trough of $2.7064, indicating an +851.92% surge from the present price of $1.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.0976 | $2.7064 | $4.1776 | +247.26% |
| February, 2026 | $7.3053 | $3.7189 | $19.76 | +519.09% |
| March, 2026 | $6.391 | $5.8302 | $7.7797 | +441.61% |
| April, 2026 | $9.7431 | $5.783 | $13.53 | +725.69% |
| May, 2026 | $11.00 | $7.404 | $12.56 | +832.61% |
| June, 2026 | $9.4264 | $8.0056 | $11.33 | +698.85% |
| July, 2026 | $8.5385 | $7.3973 | $9.3841 | +623.60% |
| August, 2026 | $11.82 | $8.5689 | $13.74 | +901.71% |
| September, 2026 | $9.8323 | $8.5523 | $15.47 | +733.24% |
| October, 2026 | $9.764 | $8.3431 | $9.954 | +727.45% |
| November, 2026 | $9.6856 | $8.5448 | $11.21 | +720.82% |
| December, 2026 | $9.5777 | $9.1477 | $11.04 | +711.67% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sellas Life Sciences Group Inc (SLS) is $6.3467, with a high forecast of $10.18 and a low forecast of $2.5132. This indicates an +437.86% increase from the last price of $1.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.0794 | $8.6986 | $9.6481 | +669.44% |
| February, 2027 | $7.4111 | $7.1762 | $10.18 | +528.06% |
| March, 2027 | $6.7932 | $6.2527 | $7.6419 | +475.69% |
| April, 2027 | $5.9348 | $5.604 | $6.8636 | +402.95% |
| May, 2027 | $5.8165 | $4.6557 | $6.5357 | +392.92% |
| June, 2027 | $6.4986 | $5.7578 | $7.0173 | +450.73% |
| July, 2027 | $7.0903 | $5.109 | $7.8099 | +500.87% |
| August, 2027 | $3.4319 | $3.3519 | $4.6607 | +190.84% |
| September, 2027 | $3.374 | $2.5132 | $4.1136 | +185.94% |
| October, 2027 | $2.7057 | $2.5657 | $3.5453 | +129.30% |
| November, 2027 | $3.0374 | $2.5165 | $3.1473 | +157.41% |
| December, 2027 | $3.5195 | $2.7686 | $3.8594 | +198.26% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2028
In 2028, Sellas Life Sciences Group Inc (SLS) is projected to reach an average price of $3.8056, with a high projection of $6.0058 and a low estimate of $1.6054. This indicates an +222.51% rise from the last price of $1.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4011 | $3.3411 | $3.9003 | +188.23% |
| February, 2028 | $2.4428 | $2.4228 | $3.592 | +107.02% |
| March, 2028 | $5.1049 | $2.1937 | $5.3249 | +332.62% |
| April, 2028 | $2.8066 | $2.5412 | $6.0058 | +137.85% |
| May, 2028 | $2.6987 | $2.4287 | $3.1074 | +128.70% |
| June, 2028 | $3.7004 | $2.5291 | $3.9504 | +213.59% |
| July, 2028 | $3.692 | $3.5312 | $4.562 | +212.88% |
| August, 2028 | $1.8041 | $1.7441 | $4.4129 | +52.89% |
| September, 2028 | $1.9858 | $1.6054 | $2.1758 | +68.29% |
| October, 2028 | $2.1175 | $1.757 | $2.1766 | +79.45% |
| November, 2028 | $2.1496 | $1.8779 | $2.2679 | +82.17% |
| December, 2028 | $2.0112 | $1.9908 | $2.2208 | +70.44% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2029
The 2029 price forecast for Sellas Life Sciences Group Inc Stock (SLS) is $1.6551 on average, with a high prediction of $2.3561 and a low estimate of $0.954. This represents an +40.26% increase from the previous price of $1.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.0833 | $1.9629 | $2.3561 | +76.55% |
| February, 2029 | $1.935 | $1.8446 | $2.1089 | +63.98% |
| March, 2029 | $2.0567 | $1.8362 | $2.0867 | +74.29% |
| April, 2029 | $1.7483 | $1.4783 | $2.3475 | +48.16% |
| May, 2029 | $1.3582 | $1.2593 | $1.7488 | +15.10% |
| June, 2029 | $1.5321 | $1.3108 | $1.7617 | +29.84% |
| July, 2029 | $1.5138 | $1.4134 | $1.7534 | +28.29% |
| August, 2029 | $1.0959 | $0.954 | $1.6242 | -7.13% |
| September, 2029 | $1.3937 | $1.0158 | $1.4565 | +18.11% |
| October, 2029 | $1.5296 | $1.378 | $2.1792 | +29.63% |
| November, 2029 | $2.0013 | $1.4201 | $2.0313 | +69.60% |
| December, 2029 | $1.62 | $1.581 | $2.1817 | +37.29% |
Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2030
Sellas Life Sciences Group Inc Stock (SLS) is expected to reach an average price of $4.1888 in 2030, with a high forecast of $7.5868 and a low forecast of $0.7909. This signifies an +254.99% surge from the last price of $1.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.8382 | $0.8143 | $1.6208 | -28.97% |
| February, 2030 | $0.8275 | $0.7909 | $0.97 | -29.87% |
| March, 2030 | $0.8628 | $0.8094 | $0.926 | -26.88% |
| April, 2030 | $0.8338 | $0.8218 | $0.8904 | -29.34% |
| May, 2030 | $0.8191 | $0.8176 | $0.8459 | -30.58% |
| June, 2030 | $0.8353 | $0.8104 | $0.8463 | -29.22% |
| July, 2030 | $4.6159 | $0.8256 | $7.5868 | +291.18% |
| August, 2030 | $4.4493 | $4.3393 | $5.5976 | +277.06% |
| September, 2030 | $4.3418 | $4.2126 | $5.4501 | +267.95% |
| October, 2030 | $3.5718 | $3.4151 | $4.3235 | +202.70% |
| November, 2030 | $2.6002 | $2.4902 | $4.4243 | +120.35% |
| December, 2030 | $2.2635 | $2.1785 | $2.711 | +91.82% |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):